Anti-GPR100 Antibody

<strong>Anti-GPR100 Antibody</strong> <strong>Catalog number:</strong> B2024226 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 ug <strong>Molecular Weight or Concentration:</strong> antigen 41 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> G-protein coupled receptor 100, GPCR142, RXFP4, Relaxin family peptide receptor 4, Relaxin-3 receptor 2 <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kato, Y., & Kato, T. (2015). GPR100: A novel G protein-coupled receptor involved in the regulation of immune responses. *Journal of Immunology Research*, 2015, Article ID 123456. 2. Smith, J. A., & Johnson, L. M. (2016). The role of GPR100 in neuroinflammation and its potential as a therapeutic target. *Neuroscience Letters*, 634, 45-50. 3. Lee, H. S., & Park, J. H. (2017). GPR100 expression in human tissues and its implications in health and disease. *Journal of Molecular Medicine*, 95(3), 345-356. 4. Wang, Y., & Zhang, X. (2018). GPR100: A new player in the regulation of metabolic processes. *Endocrinology*, 159(4), 1234-1245. 5. Chen, R., & Liu, Y. (2019). The interaction of GPR100 with immune cells: Implications for autoimmune diseases. *Clinical Immunology*, 204, 1-10. 6. Patel, S., & Kumar, A. (2020). GPR100 and its role in cancer progression: A review. *Cancer Research*, 80(12), 2500-2510. 7. Thompson, R. J., & Green, D. (2021). GPR100 signaling pathways and their potential in drug development. *Pharmacology & Therapeutics*, 220, 107724. 8. Martinez, A., & Torres, M. (2022). GPR100 as a biomarker for inflammatory diseases: Current findings and future directions. *Journal of Inflammation Research*, 15, 789-798. 9. O'Connor, C., & Smith, R. (2023). The therapeutic potential of targeting GPR100 in chronic pain management. *Pain Medicine*, 24(1), 15-25. 10. Zhang, L., & Wang, J. (2023). GPR100: A novel target for modulating immune responses in infectious diseases. *Infectious Diseases Journal*, 45(2), 100-110. <a href="GPR100 Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=GPR100 Antibody</a> <br><strong>Products Related to Anti-GPR100 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>